IT1318691B1 - Varianti di proteine allergeniche del gruppo 2 di dermatophagoides. - Google Patents

Varianti di proteine allergeniche del gruppo 2 di dermatophagoides.

Info

Publication number
IT1318691B1
IT1318691B1 IT2000MI001986A ITMI20001986A IT1318691B1 IT 1318691 B1 IT1318691 B1 IT 1318691B1 IT 2000MI001986 A IT2000MI001986 A IT 2000MI001986A IT MI20001986 A ITMI20001986 A IT MI20001986A IT 1318691 B1 IT1318691 B1 IT 1318691B1
Authority
IT
Italy
Prior art keywords
dermatophagoides
group
protein variants
allergenic protein
variants
Prior art date
Application number
IT2000MI001986A
Other languages
English (en)
Inventor
Monica Sturaro
Angelo Viotti
Paolo Falagiani
Giovanni Mistrello
Daniela Roncarolo
Stefania Zanotta
Original Assignee
Consiglio Nazionale Ricerche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Consiglio Nazionale Ricerche filed Critical Consiglio Nazionale Ricerche
Publication of ITMI20001986A0 publication Critical patent/ITMI20001986A0/it
Priority to IT2000MI001986A priority Critical patent/IT1318691B1/it
Priority to AT01984645T priority patent/ATE311407T1/de
Priority to DE60115475T priority patent/DE60115475T2/de
Priority to PCT/EP2001/010484 priority patent/WO2002022677A2/en
Priority to ES01984645T priority patent/ES2252315T3/es
Priority to AU2002220545A priority patent/AU2002220545A1/en
Priority to EP01984645A priority patent/EP1317483B1/en
Priority to CNB018154220A priority patent/CN100469789C/zh
Priority to US09/949,889 priority patent/US6800290B2/en
Publication of ITMI20001986A1 publication Critical patent/ITMI20001986A1/it
Application granted granted Critical
Publication of IT1318691B1 publication Critical patent/IT1318691B1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43531—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from mites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/855—Proteins from animals other than mammals or birds
    • Y10S530/858—Proteins from animals other than mammals or birds insects; venom
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/868—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Insects & Arthropods (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Virology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
IT2000MI001986A 2000-09-12 2000-09-12 Varianti di proteine allergeniche del gruppo 2 di dermatophagoides. IT1318691B1 (it)

Priority Applications (9)

Application Number Priority Date Filing Date Title
IT2000MI001986A IT1318691B1 (it) 2000-09-12 2000-09-12 Varianti di proteine allergeniche del gruppo 2 di dermatophagoides.
ES01984645T ES2252315T3 (es) 2000-09-12 2001-09-11 Variantes de proteinas alergenicas del grupo 2 dermatophagoides.
DE60115475T DE60115475T2 (de) 2000-09-12 2001-09-11 VARIANTEN DES DERMATOPHAGOIDES-ALLERGENS DER p 2
PCT/EP2001/010484 WO2002022677A2 (en) 2000-09-12 2001-09-11 Variants of allergenic proteins of the group 2 of dermatophagoides
AT01984645T ATE311407T1 (de) 2000-09-12 2001-09-11 Varianten der allergenen proteine der gruppe 2 von dermatophagoides
AU2002220545A AU2002220545A1 (en) 2000-09-12 2001-09-11 Variants of allergenic proteins of the group 2 of dermatophagoides
EP01984645A EP1317483B1 (en) 2000-09-12 2001-09-11 Variants of allergenic proteins of the group 2 of dermatophagoides
CNB018154220A CN100469789C (zh) 2000-09-12 2001-09-11 尘螨属2组的变应原性蛋白质的变体
US09/949,889 US6800290B2 (en) 2000-09-12 2001-09-12 Variants of allergenic proteins of the group 2 of dermatophagoides

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2000MI001986A IT1318691B1 (it) 2000-09-12 2000-09-12 Varianti di proteine allergeniche del gruppo 2 di dermatophagoides.

Publications (3)

Publication Number Publication Date
ITMI20001986A0 ITMI20001986A0 (it) 2000-09-12
ITMI20001986A1 ITMI20001986A1 (it) 2002-03-12
IT1318691B1 true IT1318691B1 (it) 2003-08-27

Family

ID=11445782

Family Applications (1)

Application Number Title Priority Date Filing Date
IT2000MI001986A IT1318691B1 (it) 2000-09-12 2000-09-12 Varianti di proteine allergeniche del gruppo 2 di dermatophagoides.

Country Status (9)

Country Link
US (1) US6800290B2 (it)
EP (1) EP1317483B1 (it)
CN (1) CN100469789C (it)
AT (1) ATE311407T1 (it)
AU (1) AU2002220545A1 (it)
DE (1) DE60115475T2 (it)
ES (1) ES2252315T3 (it)
IT (1) IT1318691B1 (it)
WO (1) WO2002022677A2 (it)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CU22983A1 (es) * 2002-05-08 2004-09-09 Inst Finlay Composición vacunal contra las alergias y método para su obtención y empleo en el tratamiento de las mismas
EP1572091A4 (en) * 2002-07-09 2008-03-05 Genentech Inc COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING TUMORS
DE60322120D1 (de) * 2003-02-07 2008-08-21 Genentech Inc Zusammensetzungen und verfahren für verstärkte apoptose
EP1621615B1 (en) * 2003-05-07 2010-03-17 Juridical Foundation, The Chemo-Sero-Therapeutic Research Institute Method of purifying modified acarian main allergen
WO2006042558A2 (en) * 2004-10-22 2006-04-27 Novozymes A/S Group 2 mite polypeptide variants
US8449894B2 (en) * 2006-05-26 2013-05-28 City Of Hope Aspergillus vaccine preparation and methods of making and using thereof
EP2384336B1 (en) * 2008-12-30 2014-03-05 Chua, Kaw Yan A variant of mite allergen and uses thereof
EP3269730A1 (en) * 2016-07-12 2018-01-17 Universität Salzburg Allergen variant
WO2020046217A1 (en) * 2018-08-28 2020-03-05 Chulalongkorn University A nucleic acid construct for inhibiting the house dust mite allergic response

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3350794B2 (ja) * 1993-09-29 2002-11-25 アサヒビール株式会社 改変したダニ主要アレルゲン

Also Published As

Publication number Publication date
US6800290B2 (en) 2004-10-05
ATE311407T1 (de) 2005-12-15
US20020054881A1 (en) 2002-05-09
WO2002022677A2 (en) 2002-03-21
DE60115475D1 (de) 2006-01-05
ES2252315T3 (es) 2006-05-16
CN100469789C (zh) 2009-03-18
WO2002022677A3 (en) 2002-10-03
ITMI20001986A0 (it) 2000-09-12
EP1317483A2 (en) 2003-06-11
DE60115475T2 (de) 2006-07-06
EP1317483B1 (en) 2005-11-30
ITMI20001986A1 (it) 2002-03-12
CN1454213A (zh) 2003-11-05
AU2002220545A1 (en) 2002-03-26

Similar Documents

Publication Publication Date Title
DE60027135D1 (de) Inhibitoren für wachstumdifferenzierungsfaktor und ihre anwendungen
ECSP105739A (es) Anticuerpos de neutralización contra gdf-8
ATE466941T1 (de) Dns-sequenzen mit anti-repressor-aktivität
CY1105221T1 (el) Ιατρικη χρηση θυρεοειδομιμητικων ενωσεων για την θepαπευτικη αγωγη της τριχοπτωσης και φαρμακευτικες συνθεσεις
ATE479683T1 (de) Antibakterielle mittel
ATE376996T1 (de) Antibakterielle mittel
HN2000000003A (es) Antibioticos cetolidos
ATE461928T1 (de) Antibakterielle wirkstoffe
RS51737B (sr) Korišćenje inhibitora il-18
USD497742S1 (en) Desk
IT1318691B1 (it) Varianti di proteine allergeniche del gruppo 2 di dermatophagoides.
AR028705A1 (es) Bis-arilsulfonas
DE69835536D1 (de) Zusammensetzungen zur behandlung von staphylococcus aureus infektionen
NO20031860L (no) Kahalalid F
ATE497506T1 (de) Sars-verwandte proteine
UY28049A1 (es) Derivados de (6,7-dihidro-5h-imidazo(1,2-a) imidazol-3-sulfonilamino)-propionamida
BRPI0209619B8 (pt) agente promotor de crescimento capilar
BR0115534A (pt) Luciferases isoladas assim como seu emprego
ATE295838T1 (de) Benzimidazolderivate zur behandlung von mit mikroglia-aktivierung assoziierten erkrankungen wie inflammatorische, allergische, infektiöse oder autoimmune erkrankungen
ATE398188T1 (de) Für akzessorische hiv proteine kodierende dna impfstoffe
DE50308032D1 (de) Isoliertes fluoreszierendes protein aus clytia gregaria cgfp, sowie dessen verwendung
ATE343387T1 (de) S-methyl-dihydro-ziprasidon zur behandlung von augenerkrankungen.
AR024483A1 (es) Proteinas insecticidas y nematocidas
BR0206918A (pt) Uso de iloperidona
ECSP045161A (es) Piperidin-2,6-diona sustituida con heterociclo en la posición 3